Ropeginterferon alfa-2b Clinical Trials

2 actively recruiting trials across 1 location

Also known as: P1101

Pipeline

Phase 1: 1Phase 3: 1

Top Sponsors

PharmaEssentia1
H. Lee Moffitt Cancer Center and Research Institute1

Indications

Cancer2
Cutaneous T Cell Lymphoma1
Primary Myelofibrosis1
Myeloproliferative Neoplasm1

Other1 trial

P1101 in Treating Patients With Early PMF or Overt PMF at Low or Intermediate-1 Risk

Phase 3

Tampa, Florida1 trial

Ropeginterferon in Patients w/Cutaneous T-Cell Lymphoma (CTCL)

Moffitt Cancer Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.